Drugs Affecting Growth of Tumours
Drugs Affecting Growth of Tumours
edited by Herbert M. Pinedo, Carolien H. Smorenburg
- Basel Birkhäuser Basel 2006
- 1 recurso en línea (IX, 238 p.) :
- Milestones in Drug Therapy .
Antimetabolites -- DNA-intercalators the anthracyclines -- Topoisomerase inhibitors -- Tubulin interacting agents -- Vaccination therapies in solid tumors -- Oral anticancer agents -- Anti-angiogenesis agents -- Signal transduction inhibitors -- Endocrine therapy of breast cancer
During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds. This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics
9783764374075
10.1007/3-7643-7407-1 doi
Antineoplásicos
Oncología
RS431.A64 / D78 2006 EB
616.994
Antimetabolites -- DNA-intercalators the anthracyclines -- Topoisomerase inhibitors -- Tubulin interacting agents -- Vaccination therapies in solid tumors -- Oral anticancer agents -- Anti-angiogenesis agents -- Signal transduction inhibitors -- Endocrine therapy of breast cancer
During recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds. This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics
9783764374075
10.1007/3-7643-7407-1 doi
Antineoplásicos
Oncología
RS431.A64 / D78 2006 EB
616.994